(Q40707087)

English

Prospective and randomized controlled study of chemoembolization therapy in patients with advanced hepatocellular carcinoma. Cooperative Study Group for Liver Cancer Treatment in Shikoku area

scientific article published on January 1994

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Prospective and randomized controlled study of chemoembolization therapy in patients with advanced hepatocellular carcinoma. Cooperative Study Group for Liver Cancer Treatment in Shikoku area (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1 reference

based on heuristic

inferred from title

author name string

Watanabe S

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Nishioka M

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Ohta Y

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Ogawa N

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Ito S

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Yamamoto Y

6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

publication date

1 January 1994

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

33 Suppl

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

S93-6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

https://scigraph.springernature.com/pub.10.1007/bf00686676

0 references

Combination chemoembolization therapy for hepatocellular carcinoma: mainly, using cisplatin (CDDP)

1 reference

https://pubmed.ncbi.nlm.nih.gov/8137492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/8137492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and Gelfoam particles for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8137492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intra-arterial administration of epirubicin in the treatment of nonresectable hepatocellular carcinoma. Epirubicin Study Group for Hepatocellular Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8137492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma--a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). The Cooperative Study Group for Liver Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8137492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transcatheter arterial embolization using iodized oil (lipiodol) mixed with an anticancer drug for the treatment of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8137492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00686676

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40707087&oldid=1904975216"